Lipids and multiple sclerosis.
Bates
D
D
Department of Neurology, University of Newcastle upon Tyne, U.K.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004041:Dietary Fats / Q000009:adverse effects*; D004311:Double-Blind Method; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000627:therapeutic use; D008042:Linolenic Acids / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000178:diet therapy* / Q000453:epidemiology / Q000209:etiology; D017965:gamma-Linolenic Acid
D000970:Antineoplastic Agents; D004041:Dietary Fats; D005231:Fatty Acids, Unsaturated; D008041:Linoleic Acids; D008042:Linolenic Acids; D017965:gamma-Linolenic Acid; D019787:Linoleic Acid